Needle-Free allergy rescue: nasal spray could replace EpiPen
NCT ID NCT07228325
First seen Nov 17, 2025 · Last updated May 24, 2026 · Updated 24 times
Summary
This study tests a new nasal powder form of epinephrine (FMXIN002) against the standard EpiPen injection in 50 healthy adults with allergies. Researchers will measure how quickly the drug enters the blood and affects heart rate and blood pressure after one or two doses. The goal is to see if the nasal spray works as fast and safely as the shot, offering a needle-free option for treating severe allergic reactions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLERGY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Pharma Medica Research Inc
Mississauga, Canada
Conditions
Explore the condition pages connected to this study.